Covered recipient · General Payments record
MARIA GERALDINA FUENTES
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,982.22
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,914.01 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $516.38 | 5 |
| Novo Nordisk AS | $283.14 | 4 |
| ABBVIE INC. | $189.67 | 10 |
| SI-BONE, INC. | $173.26 | 1 |
| Alnylam Pharmaceuticals Inc. | $152.74 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $125.32 | 1 |
| EISAI INC. | $119.92 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $117.92 | 1 |
| Lilly USA, LLC | $115.95 | 1 |
| Lexicon Pharmaceuticals, Inc. | $104.75 | 1 |
| Astellas Pharma US Inc | $14.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.69 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759100 | CMS |
| ABBVIE INC. | $24.39 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759102 | CMS |
| ABBVIE INC. | $21.70 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759104 | CMS |
| ABBVIE INC. | $19.68 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759106 | CMS |
| ABBVIE INC. | $13.55 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759108 | CMS |
| ABBVIE INC. | $21.30 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759110 | CMS |
| ABBVIE INC. | $27.53 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759112 | CMS |
| ABBVIE INC. | $11.02 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759114 | CMS |
| ABBVIE INC. | $16.23 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759116 | CMS |
| ABBVIE INC. | $11.58 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759118 | CMS |
| Alnylam Pharmaceuticals Inc. | $122.84 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125853567 | CMS |
| Alnylam Pharmaceuticals Inc. | $29.90 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125853571 | CMS |
| Amgen Inc. | $121.84 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111578553 | CMS |
| Amgen Inc. | $122.29 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111578555 | CMS |
| Amgen Inc. | $133.13 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111578559 | CMS |
| Amgen Inc. | $17.29 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111578551 | CMS |
| Amgen Inc. | $121.83 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111578557 | CMS |
| Astellas Pharma US Inc | $14.96 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139302874 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $125.32 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086109304 | CMS |
| Eisai Inc. | $119.92 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110763101 | CMS |
| Lexicon Pharmaceuticals, Inc. | $104.75 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081717862 | CMS |
| Lilly USA, LLC | $115.95 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135147050 | CMS |
| Novo Nordisk Inc | $24.86 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096940747 | CMS |
| Novo Nordisk Inc | $119.06 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097712323 | CMS |
| Novo Nordisk Inc | $122.52 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097255870 | CMS |
| Novo Nordisk Inc | $16.70 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097812340 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $117.92 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153541086 | CMS |
| SI-BONE, INC. | $173.26 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120051760 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.